公司资料
Exact Sciences 股价、新闻与催化剂
- 股票代码:
- EXAS
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股价为何变动
Current closing-price context is not available for EXAS.
公司概览
业务概览
Exact Sciences is a molecular diagnostics company focused on cancer screening and precision oncology testing. Its most visible franchise is in colorectal cancer screening, but the broader business is built around non-invasive diagnostics and oncology-related testing.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Exact Sciences sits in diagnostics and molecular testing. It is a healthcare innovation company rather than a therapeutic biotech.
商业模式特征
The company earns revenue from diagnostic test adoption, lab workflows, and cancer-screening expansion. Investors watch test volume, reimbursement, product rollout, and the potential for additional oncology diagnostics to broaden the franchise.
生物医药行业定位
Exact Sciences sits near the diagnostics edge of the biotech landscape. It is less binary than a drug developer but still sensitive to adoption trends, reimbursement, and product performance.
未来催化剂
- Exact Sciences’ catalysts are Cologuard Plus progress, screening utilization, and any regulatory or commercial update that broadens the early-detection franchise. The next checkpoint matters because it tells investors whether the program is still moving on schedule or whether the timeline needs to be reset. A clean outcome also makes it easier to think about the next regulatory or label step instead of just the current filing.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。